Sanofi-Aventis (France) And Merck KGaA Sign Cancer Drug Deal

Bloomberg -- Sanofi-Aventis SA and Merck KGaA agreed to jointly study experimental cancer treatments. Sanofi and Darmstadt, Germany-based Merck will conduct early stage human trials of Merck’s MSC1936369B and Sanofi’s SAR245409 and SAR245408 experimental drugs, Paris-based Sanofi said in an e-mailed statement today. Financial details weren’t disclosed.

Back to news